Delivery Order SPE2DB20D9331-SPE2DB23FL0F9

Award Date 11/23/22
Potential Completion Date 12/15/22
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $28,587.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. The contract is a delivery order awarded under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,409.76 firm fixed-price delivery order is for the supply of NEXPLANON 68 mg implants, a contraceptive product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,429.38 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive implant, with an ultimate completion date of September 16, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This federal contract award, valued at $1,388.64, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for 4,567,571,204 units of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract is a firm fixed-price award with an ultimate completion date of April 1, 2025. DMS Pharmaceutical Group Inc. also holds a significant single-award Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth up to $8,576.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NEXPLANON 68 MG implants, a contraceptive product, with a performance period extending through April 5, 2024. This award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with DLA, which has a ceiling value of up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $54,699.20 firm fixed-price delivery order is for the supply of 4,562,278,510 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,573.45 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the medical supply needs of military health facilities. The award is part of a larger, single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued...
This federal contract award is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $8,204.88 and a completion date of January 19, 2024. This award is part of a larger $499,999,999 indefinite delivery contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the medical supply needs of military health facilities. The award, valued at $2,858.76, is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product, to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB23FL0F9
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order valued at $3,074.80 for the provision of NEXPLANON 68 MG IMPLANTS, a contraceptive product.

The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which has a total potential value of up to $499,999,999 and runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain is solidified through this IDC, as well as the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites.

Generated 1/9/25, 9:11 AM